Wei-Xiang Qi, MD, RT

Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Shanghai, Shanghai

Disclosures:

• Employment: none
• Compensation: none
• Ownership: none
• Leadership: none

Presentation(s):

• 3064 - First Exploration of the Characterization and Dosimetric Predictors for Absolute Lymphocyte Count Changes during nCRT with or without Pembrolizumab for Esophageal Squamous Cell Carcinoma: An Analysis

  Tuesday, October 1, 2024
  12:45 PM – 2:00 PM ET